Microarray analysis of gene expresion in T. cruzi
Microarray analysis of gene expresion in T. cruzi
批准号:
6908819
负责人:
Rick L Tarleton
金额:
$7.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2007-03-31
关键词:
DNARNATrypanosoma cruzibioinformaticsbiological signal transductionchemical stabilitycomputational biologydevelopmental geneticsfunctional /structural genomicsgene expressiongene expression profilinggenetic translationlife cyclemessenger RNAmicroarray technologymolecular biology information systemprotein quantitation /detectionproteomicsprotozoal geneticstrypanosomiasis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by the applicant): Roughly 30% of Trypanosoma cruzi infections result in potentially fatal chronic pathology known as Chagas disease. Our long-term goal is to identify likely targets for Chagas disease prevention and intervention. Prerequisite to this goal is the discovery and characterization of genes and their pattern of expression in T. cruzi. The recent completion of sequencing and annotation of the T. cruzi genome provides an unprecedented opportunity to identify new targets for vaccine and therapeutic interventions. We hypothesize that: 1) stages in the T. cruzi life cycle each have unique signatures of gene expression, 2) determining these signatures will be instructive as to the nature of the mechanisms and signaling pathways involved in stage conversion, and 3) that genes expressed non-constitutively during the T. cruzi lifecycle will include many genes that will be particularly useful targets for disease prevention and intervention. The aims of this project are to initiate the development of a high quality, annotated gene expression database of T. cruzi trypomastigotes (TRP), amastigotes (AMA), epimastigotes (EPI), and metacyclic trypomastigotes (MET). We will determine gene expression signatures using RNAs from a single time point in each life-cycle stage to interrogate DNA micro-arrays containing long oligonucleotides complementary to every annotated gene in the newly sequenced T. cruzi genome. Both total KNA and polysomal RNAs will be used in this analysis in order to investigate the relative contributions of mRNA stability and translational efficiency to control of gene expression in T. cruzi. The results of these analyses will be compared with proteomic data generated in our laboratory to determine if profiling using DNA micro-arrays accurately reflects protein presence and abundance. We will also perform a time-course study of TRP-to- AMA stage conversion to examine the fluctuations hi gene expression during this critical process in parasite development. Of the five stage transitions in the T. cruzi life cycle, the TRP-to-AMA is the most amenable to time course experimentation and is particularly relevant to the host-parasite relationship in T. cruzi-infected hosts. Moreover,
using polysomal RNA and extending the time course will build upon our previous study of this stage transition. The data and analysis of these studies, along with proteome data, will be made available to the research community by deposition in TcruziDB in a MIAME compliant format. Completion of this study will provide valuable data on the expression of genes in T. cruzi, especially the many that are "hypothetical," and provide a starting point for elucidating the functions of these genes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The activation of benzoxaborole prodrug AN15368, a clinical candidate for Chagas disease
-
批准号:10667721
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2023
-
负责人:Rick L Tarleton
-
依托单位:
Optimizing blood PCR as test of cure in Chagas disease
-
批准号:10451977
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2022
-
负责人:Rick L Tarleton
-
依托单位:
Optimizing blood PCR as test of cure in Chagas disease
-
批准号:10590740
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2022
-
负责人:Rick L Tarleton
-
依托单位:
Trypanosoma cruzi dormancy and its implications for therapeutic treatment
-
批准号:10573204
-
项目类别:
-
资助金额:$47.7万
-
财政年份:2020
-
负责人:Rick L Tarleton
-
依托单位:
Trypanosoma cruzi dormancy and its implications for therapeutic treatment
-
批准号:10368984
-
项目类别:
-
资助金额:$47.7万
-
财政年份:2020
-
负责人:Rick L Tarleton
-
依托单位:
Purchase of an imaging flow cytometer 2016
-
批准号:9273704
-
项目类别:
-
资助金额:$45.38万
-
财政年份:2017
-
负责人:Rick L Tarleton
-
依托单位:
Mechanisms of persistence in Trypanosoma cruzi infection
-
批准号:9754759
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2016
-
负责人:Rick L Tarleton
-
依托单位:
Multiplex treatment outcomes test for Chagas disease
-
批准号:9305839
-
项目类别:
-
资助金额:$100.08万
-
财政年份:2016
-
负责人:Rick L Tarleton
-
依托单位:
Mechanisms of persistence in Trypanosoma cruzi infection
-
批准号:9237877
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2016
-
负责人:Rick L Tarleton
-
依托单位:
Mechanisms of persistence in Trypanosoma cruzi infection
-
批准号:9979735
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2016
-
负责人:Rick L Tarleton
-
依托单位:
Generation of reference genomes for Trypanosoma cruzi using PacBio sequencing
-
批准号:9251753
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2016
-
负责人:Rick L Tarleton
-
依托单位:
Development of CRISPR/Cas system for study of trans-sialidase family genes in T. cruzi
-
批准号:9054467
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2016
-
负责人:Rick L Tarleton
-
依托单位:
Making benznidazole a better drug for Chagas disease
-
批准号:8652132
-
项目类别:
-
资助金额:$18.64万
-
财政年份:2014
-
负责人:Rick L Tarleton
-
依托单位:
Making benznidazole a better drug for Chagas disease
-
批准号:8903699
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:Rick L Tarleton
-
依托单位:
Transmission-blocking live vaccine for Chagas disease
-
批准号:8968183
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2011
-
负责人:Rick L Tarleton
-
依托单位:
Transmission-blocking live vaccine for Chagas disease
-
批准号:8585810
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2011
-
负责人:Rick L Tarleton
-
依托单位:
Transmission-blocking live vaccine for Chagas disease
-
批准号:8237761
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2011
-
负责人:Rick L Tarleton
-
依托单位:
Transmission-blocking live vaccine for Chagas disease
-
批准号:8390470
-
项目类别:
-
资助金额:$34.9万
-
财政年份:2011
-
负责人:Rick L Tarleton
-
依托单位:
Multi-color Flow Analyzer for the UGA-CTEGD Flow Facility
-
批准号:7794363
-
项目类别:
-
资助金额:$34.79万
-
财政年份:2010
-
负责人:Rick L Tarleton
-
依托单位:
Multiplex serodiagnostic test for Chagas disease
-
批准号:8103493
-
项目类别:
-
资助金额:$78.25万
-
财政年份:2010
-
负责人:Rick L Tarleton
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程子译
-
依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
-
批准号:2026JJ81091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘亮
-
依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
-
批准号:JCZRLH202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
基于异质人群多源数据识别单细胞 RNA数量性状风险位点的统计学方法研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蔡铭轩
-
依托单位:
uN2CpolyG蛋白经ALYREF蛋白介导RNA转运异常在神经元核内包涵体病发病中的作用及机制研究
-
批准号:2026JJ60587
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张思哲
-
依托单位:
病毒非编码RNA多样性图谱构建及其生物发生与致病机制研究
-
批准号:2026JJ60389
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:傅萍
-
依托单位:
核糖核酸酶RNase E与其抑制因子RebA通过液-液相分离调控蓝藻RNA代谢的分子机制
-
批准号:JCZRQNB202600879
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: